niacinamide has been researched along with glucose, (beta-d)-isomer in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (57.14) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Levine, BB; May, CD; Weissmann, G | 1 |
| Hales, K; Little, CJ; Stahel, O | 1 |
| Caputi, AP; Cuzzocrea, S; Zingarelli, B | 2 |
| Bretzel, RG; Federlin, K; Hering, BJ; Jahr, H; Weinand, S | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Zingarelli, B | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Sottile, A; Teti, D; Zingarelli, B | 1 |
| PFLEIDERER, G; VOLZ, M; WOENCKHAUS, C | 1 |
| Ashihara, H; Deng, WW; Watanabe, S; Yin, Y | 1 |
| Ashihara, H; Watanabe, S; Yin, Y | 1 |
| Hayashizaki, Y; Imamura, M; Kihara, R; Kobayashi, Y; Kurosaki, E; Noda, A; Qun, L; Sasamata, M; Shibasaki, M; Tahara, A; Takasu, T; Tomiyama, H; Yamajuku, D; Yokono, M | 1 |
| Ashihara, H; Katahira, R; Mimura, T; Sasamoto, H; Watanabe, S; Yin, Y | 1 |
| Horwitz, S; Rendon, M | 1 |
| Akahane, K; Inoue, T; Kiguchi, S; Kobayashi, M; Maruyama, K; Mori, Y; Ojima, K; Yaguchi, A; Yokoyama, A | 1 |
| Rupasinghe, HV; Sudan, S | 1 |
| Imamura, M; Kurosaki, E; Tahara, A; Takasu, T; Yokono, M | 1 |
| Abas, F; Arulselvan, P; Cheah, PS; Fakurazi, S; Muhammad, AA | 1 |
| Buharalioglu, CK; Guden, DS; Kacan, M; Korkmaz, B; Malik, KU; Sahan-Firat, S; Sari, AN; Tamer-Gumus, L; Temiz-Resitoglu, M; Tunctan, B; Unsal, D; Yildirim-Yaroglu, H | 1 |
| Buharalioglu, CK; Cil, M; Guden, DS; Korkmaz, B; Malik, KU; Sahan-Firat, S; Sari, AN; Senol, SP; Temiz-Resitoglu, M; Tunctan, B; Unsal, D | 1 |
| Idrees, M; Joo, MD; Kong, IK; Lee, KL; Liu, H; Mesalam, A; Xu, L; Yuan, YG; Zhang, S | 1 |
| Abd El-Hameed, AM; Abd El-Twab, SM; Abdel-Moneim, A; El-Shahawy, AAG; Yousef, AI | 1 |
1 review(s) available for niacinamide and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Topical treatment of hyperpigmentation disorders.
Topics: Administration, Topical; Adrenal Cortex Hormones; Arbutin; Chromones; Drug Combinations; Free Radical Scavengers; Glucosides; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Monophenol Monooxygenase; Niacinamide; Phytotherapy; Plant Preparations; Randomized Controlled Trials as Topic; Receptor, PAR-2; Retinoids; Skin Diseases; Skin Lightening Preparations; Skin Pigmentation | 2012 |
20 other study(ies) available for niacinamide and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Effects of compounds which inhibit antigenic release of histamine and phagocytic release of lysosomal enzyme on glucose utilization by leukocytes in humans.
Topics: Adenine Nucleotides; Antigens; Carbon Dioxide; Carbon Isotopes; Caseins; Cyclic AMP; Depression, Chemical; Ethanol; Glucose; Glucuronidase; Histamine Release; Humans; In Vitro Techniques; Lactoglobulins; Leukocytes; Lysosomes; Niacinamide; Phagocytosis; Pollen; Theophylline; Zymosan | 1970 |
The role of column switching in analysing complex samples.
Topics: Anticonvulsants; Carboxylic Acids; Chromatography, High Pressure Liquid; Diterpenes; Diterpenes, Kaurane; Glucosides; Humans; Niacinamide; Nicotinic Acids; Plants; Terpenes; Wine | 1984 |
Peroxynitrate-mediated DNA strand breakage activates poly(ADP-ribose) synthetase and causes cellular energy depletion in a nonseptic shock model induced by zymosan in the rat.
Topics: Animals; Benzamides; Disease Models, Animal; DNA Damage; Energy Metabolism; Enzyme Activation; Macrophages, Peritoneal; Male; Mitochondria; NAD; NG-Nitroarginine Methyl Ester; Niacinamide; Nitrates; Nitric Oxide Synthase; Oxidants; Oxygen Consumption; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Shock; Zymosan | 1998 |
Role of peroxynitrite and poly (ADP-ribosyl) synthetase activation in cardiovascular derangement induced by zymosan in the rat.
Topics: Animals; Aortic Diseases; Benzamides; Enzyme Activation; Enzyme Inhibitors; Immunohistochemistry; Injections, Intraperitoneal; Male; Niacinamide; Nitrates; Oxidants; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Shock, Cardiogenic; Tyrosine; Zymosan | 1998 |
Oxygen radical production in human mononuclear blood cells is not suppressed by drugs used in clinical islet transplantation.
Topics: Diabetes Mellitus, Type 1; Humans; Immunosuppressive Agents; Interleukin-1; Islets of Langerhans Transplantation; Leukocytes, Mononuclear; Lipopolysaccharides; Lymphocyte Activation; Methylprednisolone; Niacinamide; Superoxides; Tumor Necrosis Factor-alpha; Zymosan | 1999 |
Protective effects of poly (ADP-ribose) synthase inhibitors in zymosan-activated plasma induced paw edema.
Topics: Animals; Benzamides; Complement Activation; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Free Radicals; Immunohistochemistry; Inflammation; Male; Niacinamide; Nitrates; Peroxidase; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Tyrosine; Zymosan | 1999 |
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
Topics: Animals; Benzamides; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Multiple Organ Failure; Niacinamide; Nitrates; Peritonitis; Poly(ADP-ribose) Polymerase Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Time Factors; Zymosan | 1999 |
[DEMONSTRATION AND PROPERTIES OF NICOTINAMIDE-N1-BETA-D-GLUCO-PYRANOSYLPHOSPATE AND NICOTINAMIDE-GLUCOSIDE-ADENINE-DINUCLEOTIDE].
Topics: Adenine; Chemical Phenomena; Chemistry; Glucosides; NAD; Niacin; Niacinamide; Nucleotides; Research | 1964 |
Pyridine salvage and nicotinic acid conjugate synthesis in leaves of mangrove species.
Topics: Alkaloids; Avicennia; Deamination; Decarboxylation; Glucosides; Isotopes; NAD; NADP; Niacinamide; Nicotinic Acids; Nucleotides; Plant Leaves; Plant Roots; Pyridines; Rhizophoraceae; Salt Tolerance; Sodium Chloride | 2010 |
Nicotinamide metabolism in ferns: formation of nicotinic acid glucoside.
Topics: Alkaloids; Ferns; Glucosides; Niacin; Niacinamide; Plant Leaves; Pyridines; Sodium Chloride | 2011 |
Antidiabetic effects of SGLT2-selective inhibitor ipragliflozin in streptozotocin-nicotinamide-induced mildly diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucose Tolerance Test; Glucosides; Hypoglycemic Agents; Insulin; Kidney; Male; Mice; Mice, Inbred ICR; Niacinamide; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Thiophenes | 2012 |
Comparison of the formation of nicotinic acid conjugates in leaves of different plant species.
Topics: Alkaloids; Carbon Radioisotopes; Embryophyta; Glucosides; NAD; Niacin; Niacinamide; Nicotinamide Mononucleotide; Plant Leaves; Species Specificity; Time Factors | 2012 |
Efficacy of Mitiglinide Combined with Dapagliflozin in Streptozotocin-nicotinamide-induced Type 2 Diabetic Rats and in Zucker Fatty Rats.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucose Tolerance Test; Glucosides; Hypoglycemic Agents; Insulin; Isoindoles; Niacinamide; Rats; Rats, Zucker; Streptozocin | 2015 |
Antiproliferative activity of long chain acylated esters of quercetin-3-O-glucoside in hepatocellular carcinoma HepG2 cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Cycle; Cell Proliferation; Cisplatin; DNA Fragmentation; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Esters; Fatty Acids; Flavonoids; Glucosides; Hep G2 Cells; Humans; Liver Neoplasms; Microscopy, Fluorescence; Niacinamide; Phenylurea Compounds; Quercetin; Sorafenib | 2015 |
Effects of the combination of SGLT2 selective inhibitor ipragliflozin and various antidiabetic drugs in type 2 diabetic mice.
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucosides; Hypoglycemic Agents; Kidney; Male; Mice, Inbred ICR; Niacinamide; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Thiophenes; Time Factors | 2016 |
Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal model.
Topics: Animals; Anti-Bacterial Agents; Apigenin; Diabetes Mellitus, Experimental; Diabetic Foot; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli; Glucosides; Male; Microbial Sensitivity Tests; Moringa oleifera; Niacinamide; Plant Extracts; Pseudomonas aeruginosa; Rats, Wistar; Staphylococcus aureus; Streptozocin; Structure-Activity Relationship; Water; Wound Healing | 2016 |
The role of Syk/IĸB-α/NF-ĸB pathway activation in the reversal effect of BAY 61-3606, a selective Syk inhibitor, on hypotension and inflammation in a rat model of zymosan-induced non-septic shock.
Topics: Animals; Gene Expression Regulation; I-kappa B Kinase; Male; NF-kappa B; Niacinamide; Pyrimidines; Rats; Rats, Wistar; Shock; Syk Kinase; Zymosan | 2018 |
NF-κB activation mediates LPS-or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock.
Topics: Animals; Cyclooxygenase 2; Disease Models, Animal; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Hypotension; Inflammation; Interleukin-8; Lipopolysaccharides; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Niacinamide; Nitric Oxide Synthase Type II; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Wistar; Shock, Septic; Syk Kinase; Tumor Necrosis Factor-alpha; Zymosan | 2019 |
Polydatin and I-CBP112 protects early bovine embryo against nicotinamide-induced mitochondrial dysfunction.
Topics: Acetylation; Animals; Apoptosis; Cattle; Cyclooxygenase 2; Embryo Culture Techniques; Embryonic Development; Glucosides; Histones; Membrane Potential, Mitochondrial; NF-kappa B; Niacinamide; Oxazepines; Oxidative Stress; Piperidines; Reactive Oxygen Species; Stilbenes; Tumor Suppressor Protein p53 | 2019 |
Hepatoprotective Effects of Polydatin-Loaded Chitosan Nanoparticles in Diabetic Rats: Modulation of Glucose Metabolism, Oxidative Stress, and Inflammation Biomarkers.
Topics: Animals; Chitosan; Diabetes Mellitus, Experimental; Glucose; Glucosides; Inflammation; Lipid Peroxidation; Liver; Male; Metformin; Nanoparticles; Niacinamide; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Stilbenes; Streptozocin | 2021 |